Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Coverage (5)

• SCTX IPO News - Cardiovascular diseases biotech Scribe Therapeutics files for a $75 million IPO renaissancecapital.com · 1d ago
• Meet the gene-editing, cholesterol-fighting Alameda company looking for IPO riches The Business Journals · 1d ago
• Scribe Therapeutics files for proposed Nasdaq IPO By Investing.com Investing.com South Africa · 1d ago
• Scribe Therapeutics Stockholders Include Eli Lilly Moomoo · 1d ago
• Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs Endpoints News · 1d ago

Related trends